Open Access

Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain

  • Daniela Impellizzeri1,
  • Giuseppe Bruschetta1,
  • Marika Cordaro1,
  • Rosalia Crupi1,
  • Rosalba Siracusa1,
  • Emanuela Esposito1 and
  • Salvatore Cuzzocrea1, 2Email author
Contributed equally
Journal of Neuroinflammation201613:129

https://doi.org/10.1186/s12974-016-0595-6

Received: 24 May 2016

Accepted: 24 May 2016

Published: 31 May 2016

The original article was published in Journal of Neuroinflammation 2014 11:136

Erratum

The authors would like to issue an erratum for this article [1], and would like to declare the following competing interests which we inadvertently failed to include in our original publication. The authors would like to apologise for this omission.

Competing interests

Dr. Salvatore Cuzzocrea, researcher on the study team, is co-inventor on patent WO2013121449 A8 (Epitech Group SpA) which deals with compositions and methods for the modulation of amidases capable of hydrolysing N-acylethanolamines useable in the therapy of inflammatory diseases. Moreover, Dr. Cuzzocrea is also a co-inventor with Epitech group on the following patents:
  1. 1.

    EP 2 821 083

     
  2. 2.

    MI2014 A001495

     
  3. 3.

    102015000067344

     

No other authors have competing interests.

Notes

Declarations

Ethics approval and consent to participate

The study [1] was approved by the University of Messina Animal Care Review Board: protocol number 8/U-apr 16.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Biological and Environmental Sciences, University of Messina
(2)
Manchester Biomedical Research Centre, Manchester Royal Infirmary, University of Manchester

Reference

  1. Impellizzeri D, Bruschetta G, Cordaro M, Crupi R, Siracusa R, Esposito E, Cuzzocrea S. Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain. J Neuroinflammation. 2014;11:136. doi:10.1186/s12974-014-0136-0.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement